Randomized phase II study of concurrent versus sequential alternating gefitinib and chemotherapy in previously untreated non-small cell lung cancer with sensitive EGFR mutations: NEJ005/TCOG0902Shunichi Sugawara, T. Nukiwa, Yasuko Fujita et al.|Annals of Oncology|2015Cited by 111
A phase II study of bevacizumab with carboplatin-pemetrexed in non-squamous non-small cell lung carcinoma patients with malignant pleural effusions: North East Japan Study Group Trial NEJ013AKazuhiro Usui, Kunihiko Kobayashi, Shunichi Sugawara et al.|Lung Cancer|2016Cited by 48
Randomized phase II study of concurrent gefitinib and chemotherapy versus sequential alternating gefitinib and chemotherapy in previously untreated non-small cell lung cancer (NSCLC) with sensitive <i>EGFR</i> mutations: NEJ005/TCOG0902.Satoshi Oizumi, Shunichi Sugawara, Koichi Minato et al.|Journal of Clinical Oncology|2014Cited by 6